| MAO | 1) MonoAmine Oxidase 2) Maximal Acid Output |
|---|---|
| MAOI | MonoAmine Oxidase Inhibitors |
| MA | malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern... |
| MAO | Master of the Art of Obstetrics; maximal acid output; monoamine oxidase |
| MAOA | monoamine oxidase A |
| MAO | Catechol-0-methyltransferase and monoamine oxidase |
|---|---|
| MAOI | Monoamine oxidase inhibitor |
| MAO | Monoamine Oxidase |
| MAO | Monoamine oxidase activity |
| MAO A | Monoamine oxidase type A |
| glucose oxyhydrase | <enzyme> An enzyme which converts glucose into gluconic acid and hydrogen peroxide (H2O2). It is used to help diagnose diabetes by determining if glucose is present in the patients urine, if the glucose is present, the hydrogen peroxide produced in the reaction can be detected by reacting it with an indicator to change the colour of the urine. (09 Oct 1997) |
|---|---|
| diamino oxyhydrase | amine oxidase (copper-containing) |
| monoamine | <biochemistry> A molecule containing one amine group. Synonym: monamine. (05 Mar 2000) |
| monoamine neurotransmitters | A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology. (12 Dec 1998) |
| monoamine oxidase | <enzyme> Catalysing breakdown of several biogenic amines, such as serotonin, adrenaline, noradrenaline, dopamine. (18 Nov 1997) |
| monoamine oxidase inhibitor | <pharmacology> A drug that interferes with the action of monoamine oxidase, slowing the breakdown of certain neurotransmitters. Used in the treatment of depression. Monoamine oxidase inhibitors are a group of antidepressant drugs that prevent the activity of the enzyme monoamine oxidase in the central nervous system (brain) thus affecting mood. The use of these medications is often restricted due to their severe side effects and drug (and food) interactions. Examples include isocarboxazid, pargyline, selegiline, furazolidone and phenelzine. Acronym: MAOI (26 Mar 1998) |
| monoamine oxidase inhibitors | A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. Although mao inhibitors are probably as effective as tricyclic antidepressants in the treatment of major depression, the complex, sometimes severe, and often unpredictable interactions between mao inhibitors and many other drugs and food-derived amines make their medical use difficult and potentially hazardous. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|